Clinical Significance of sIL-2R Levels in B-Cell Lymphomas-Reference-Cited by-同舟云学术

Clinical Significance of sIL-2R Levels in B-Cell Lymphomas

Published:2013-11-13 Issue:11 Volume:8 Page:e78730
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Yoshida Noriaki,Oda Miyo,Kuroda Yoshiaki,Katayama Yuta,Okikawa Yoshiko,Masunari Taro,Fujiwara Megumu,Nishisaka Takashi,Sasaki Naomi,Sadahira Yoshito,Mihara Keichiro,Asaoku Hideki,Matsui Hirotaka,Seto Masao,Kimura Akiro,Arihiro Koji,Sakai Akira

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference38 articles.

1. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro;LA Rubin;J Immunol,1985

2. Soluble interleukin-2 receptor in cancer;S Murakami;Front Biosci,2004

3. Soluble interleukin 2 receptors in sera of Japanese patients with adult T cell leukemia mark activity of disease;N Yasuda;Blood,1988

4. The molecular basis for the generation of the human soluble interleukin 2 receptor;LA Rubin;Cytokine,1990

5. Significance of soluble interleukin-2 receptor levels for evaluation of the progression of adult T-cell leukemia;S Kamihira;Cancer,1994

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting CD25+ lymphoma cells with the antibody–drug conjugate camidanlumab tesirine as a single agent or in combination with targeted agents;British Journal of Haematology;2024-07-30

2. Soluble receptors in cancer: mechanisms, clinical significance, and therapeutic strategies;Experimental & Molecular Medicine;2024-01-05

3. Macrophage activation syndrome;The Rose and Mackay Textbook of Autoimmune Diseases;2024

4. Reigniting hope in cancer treatment: the promise and pitfalls of IL-2 and IL-2R targeting strategies;Molecular Cancer;2023-07-29

5. Targeting CD25-positive lymphoma cells with the antibody-drug conjugate camidanlumab tesirine as single agent or in combination with targeted agents;2023-07-02